… ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform LEIDEN, Netherlands & CAMBRIDGE, Mass., … call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently …
… and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration Partnership focused on utilizing … RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced a …
… ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB LEIDEN, the … ProQR will deliver a presentation on the Axiomer ® RNA editing technology during the TIDES: Oligonucleotide and …
… Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology Key updates ProQR presents in … proof of concept for its novel and proprietary Axiomer ® RNA editing platform technology. Axiomer ® technology Editing …
… its clinical stage pipeline programs and the Axiomer ® RNA editing platform. ProQR leadership will highlight key … design and assumptions. The QR-421a, QR-1123, QR-504a, and RNA editing platform technologies will also be featured. …
… Operating and Financial Results Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, … RNA therapies based on its proprietary Axiomer RNA editing technology platform, today reported its financial …
… RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will … Therapeutics II Poster Presentations Title: ADAR-Mediated RNA Editing-Based Correction of PNPLA3 I148M Functionality to …
… RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today reported its financial … the past year as we exclusively focused our strategy on RNA editing, ProQR made important progress with Axiomer, our …